About United BioSource Corporation
United BioSource Corporation is a company based in Blue Bell (United States) founded in 2003 was acquired by Avista Capital Partners in November 2017.. United BioSource Corporation has raised $278 million across 3 funding rounds from investors including J P Morgan, PNC and Express Scripts. United BioSource Corporation has completed 5 acquisitions, including BioCor, Cognitive Drug Research and Examoto. United BioSource Corporation offers products and services including Evidence Development, Safety and Risk Management, Patient Access, and Technology Solutions. United BioSource Corporation operates in a competitive market with competitors including Launch Therapeutics, Xgene Pharmaceutical, Hikinger Pharmaceutical Technology, Ipsum and Concentrics Research, among others.
- Headquarter Blue Bell, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Ubc Late Stage (Uk) Limited
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$278 M (USD)
in 3 rounds
-
Latest Funding Round
$150 M (USD), Debt – Conventional
Jul 06, 2010
-
Investors
J P Morgan
& 9 more
-
Employee Count
Employee Count
-
Investments & Acquisitions
BioCor
& 4 more
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of United BioSource Corporation
United BioSource Corporation offers a comprehensive portfolio of products and services, including Evidence Development, Safety and Risk Management, Patient Access, and Technology Solutions. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Solutions for generating real-world evidence and analytics.
Services to manage product safety and compliance.
Programs for improving therapy affordability and adherence.
Tools to accelerate innovation and data insights.
Unlock access to complete
Software Development Team
47 people
Leadership Team
30 people
Senior Team
28 people
Clinical Team
15 people
Safety Team
15 people
Data Analysis and Operations Team
15 people
Finance and Accounting
11 people
Sales and Marketing
9 people
Unlock access to complete
Funding Insights of United BioSource Corporation
United BioSource Corporation has successfully raised a total of $278M across 3 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $150 million completed in July 2010. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Debt – Conventional — $150.0M
-
First Round
First Round
(01 Dec 2003)
- Investors Count 8
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2010 | Amount | Debt – Conventional - United BioSource Corporation | Valuation |
investors |
|
| Oct, 2009 | Amount | Private Equity Round - United BioSource Corporation | Valuation |
investors |
|
| Dec, 2003 | Amount | Private Equity Round - United BioSource Corporation | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in United BioSource Corporation
United BioSource Corporation has secured backing from 10 investors, including institutional and venture fund investors. Prominent investors backing the company include J P Morgan, PNC and Express Scripts. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity investments are directed toward growth-stage companies.
|
Founded Year | Domain | Location | |
|
Early-stage US tech startups are invested in by Grotech Ventures.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by United BioSource Corporation
United BioSource Corporation has strategically engaged in corporate development activities, having acquired 5 companies. Notable acquisitions include BioCor, Cognitive Drug Research and Examoto. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
IT services are provided to the healthcare sector.
|
2012 | ||||
|
Software solutions for pharmacovigilance reporting and analysis are provided.
|
2000 | ||||
|
Pharmacy benefits are managed for healthcare clients by Pharmastar.
|
1997 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - United BioSource Corporation
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
United Biosource Corporation Comparisons
Competitors of United BioSource Corporation
United BioSource Corporation operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Launch Therapeutics, Xgene Pharmaceutical, Hikinger Pharmaceutical Technology, Ipsum and Concentrics Research, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Late-stage clinical development services are provided for biopharma companies.
|
|
| domain | founded_year | HQ Location |
Developer of pharmaceutical products for treating neurological diseases and chronic pain
|
|
| domain | founded_year | HQ Location |
Phase I-IV drug research and development services are provided.
|
|
| domain | founded_year | HQ Location |
Full-service CRO support for Phase II-IV clinical trials is provided.
|
|
| domain | founded_year | HQ Location |
Late-stage (Phase II-IV trials) CRO
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on United Biosource Corporation
Frequently Asked Questions about United BioSource Corporation
When was United BioSource Corporation founded?
United BioSource Corporation was founded in 2003.
Where is United BioSource Corporation located?
United BioSource Corporation is headquartered in Blue Bell, United States. It is registered at Blue Bell, Pennsylvania, United States.
Is United BioSource Corporation a funded company?
United BioSource Corporation is a funded company, having raised a total of $278M across 3 funding rounds to date. The company's 1st funding round was a Private Equity Round of $153M, raised on Dec 01, 2003.
What does United BioSource Corporation do?
United BioSource Corporation provides pharmaceutical support services. Services include clinical development and late stage clinical research, trial management, risk monitoring, risk evaluation and mitigation strategies, risk management plans, reimbursement patient assistance, along with support programs designed to enhance patients adherence. It also offers CLÆRITY and SÆfetyworks web based analytical softwares and has partnered with Accredo Specialty Pharmacy and CuraScript Specialty Distribution to help pharmaceutical and biotech manufacturers maximize product access and commercialization.
Who are the top competitors of United BioSource Corporation?
United BioSource Corporation's top competitors include Xgene Pharmaceutical, Concentrics Research and Hikinger Pharmaceutical Technology.
What products or services does United BioSource Corporation offer?
United BioSource Corporation offers Evidence Development, Safety and Risk Management, Patient Access, and Technology Solutions.
How many acquisitions has United BioSource Corporation made?
United BioSource Corporation has made 5 acquisitions, including BioCor, Cognitive Drug Research, and Examoto.
Who are United BioSource Corporation's investors?
United BioSource Corporation has 10 investors. Key investors include J P Morgan, PNC, Express Scripts, Wells Fargo, and Berkshire Partners.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.